Evidence map›Paper›PMID 41632331›Full record

ReviewPlant molecular biology2026

Applications of omics in deciphering the unique traits of durian, the king of fruits.

Chee-Wei Yew, Ching-Ching Wee

Abstract readReview
In one paragraph

Review in Plant molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chee-Wei YewBiotechnology Research Institute, Universiti Malaysia Sabah, 88400, Kota Kinabalu, Sabah, Malaysia.
Ching-Ching WeeBiotechnology Research Institute, Universiti Malaysia Sabah, 88400, Kota Kinabalu, Sabah, Malaysia. ccwee@ums.edu.my.ORCID http://orcid.org/0000-0002-9109-8888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Durio zibethinus, commonly known as the "king of the fruits," is widely cultivated in Southeast Asia, contributing significantly to the region's economy. In addition to commercial cultivars, numerous local edible durian species are also found in these countries. With the rapid advancement of omics technologies, extensive studies have been conducted on durians using various omics approaches. To date, omics studies have primarily focused on commercial durians (D. zibethinus), with relatively less emphasis on endemic, minimally commercialized local durians (Durio sp.). As such, this review summarizes all omics studies performed on both commercial cultivars and local durians of different species. In addition, it explores their applications in evolutionary studies, understanding the fruit ripening mechanism, identifying genetic markers for breeding, and uncovering their pharmaceutical and industry potential, as well as post-harvest processing. Furthermore, the current limitations of durian omics studies and future research prospects are discussed.

Indexed as

FruitGenomicsGenetic MarkersMetabolomicsMultiomicsPlant BreedingProteomicsGenetic MarkersApplicationsDurianMonthongMusang KingOmics

Identifiers

PMID41632331
PMCPMC12868020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.